Accueil   Diary - News   All news Koelis announces first procedures in its clinical study VIOLETTE

Koelis announces first procedures in its clinical study VIOLETTE

 

Koelis announces first procedures in 3D fusion imaging-guided
focal ablation of prostate cancer in its clinical study VIOLETTE

 


MEYLAN, France, April 8th, 2021 – KOELIS, an international leader in prostate fusion imaging, announces enrolling the first patients in the VIOLETTE clinical trial (NCT04582656) on 3D fusion imaging-guided focal ablation of prostate cancer.

 


Prostate cancer is the most common cancer among men. In the past ten years, prostate imagingdevelopments allowed to reduce overdiagnosis and overtreatment of prostate cancer. Focal treatment is a novel approach aiming at treating only the prostatic lesion while sparing healthy tissue. KOELIS 3D technologies are fundamental assets to precisely deliver and execute focal treatment.

 

READ THE PRESS RELEASE